The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples.
about
Fatty acids as therapeutic auxiliaries for oral and parenteral formulationsAdoptive cell therapy for sarcomaT-Cell-Based Immunotherapy for Osteosarcoma: Challenges and OpportunitiesTargeting of drugs and nanoparticles to tumors.Interleukin 11 is upregulated in uterine lavage and endometrial cancer cells in women with endometrial carcinoma.Identification of novel immunoregulatory molecules in human thymic regulatory CD4+CD25+ T cells by phage displayA radiolabeled nonapeptide probe targeting PC-3 cells and bone metastases of prostate cancer in mice.Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man studyLigand-targeted theranostic nanomedicines against cancerA role for transcription factor STAT3 signaling in oncogene smoothened-driven carcinogenesis.Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells.Multiple target-specific molecular agents for detection and image analysis of breast cancer characteristics in mice.Genetically modified T cells targeting interleukin-11 receptor α-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases.Identification of IL11RA and MELK amplification in gastric cancer by comprehensive genomic profiling of gastric cancer cell lines.More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer.MR molecular imaging of tumor vasculature and vascular targets.Drug design strategies for the treatment of prostate cancer.IL-11 signaling as a therapeutic target for cancer.BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation.Adoptive T-Cell Therapy for Solid Tumors.Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity.Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens.Non-core region modulates interleukin-11 signaling activity: generation of agonist and antagonist variants.Targeting mammalian organelles with internalizing phage (iPhage) libraries.Tumor self-seeding by circulating tumor cells in nude mouse models of human osteosarcoma and a preliminary study of its mechanisms.IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets.Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion
P2860
Q26828805-8BD79310-D5C6-4182-AE17-576B5945FC4AQ27009541-12278E7E-5A79-420F-80CD-F57F50270B48Q28074619-C41E6903-A328-44C1-BD74-A626163A7C0DQ33751710-F5AFA066-8FB4-4C04-BE73-0BC773AAA207Q33981250-DE48BB85-3C76-4E1F-AC3D-D4021949006CQ33988297-7D9D175F-C3C7-4932-AE34-ED65726B5321Q34204255-A249B6CB-0BED-47CD-94D1-6E509FE3A16DQ35592471-6C4A0940-83A8-4AB9-BC8D-B39C1452A659Q35895637-B7C0A5EB-CF25-4255-A029-F438AFD138FEQ36368350-EC7FEF31-9ED9-4983-88AD-9E99F9F9267DQ36733388-2FF23368-B99F-4234-8625-30E2DBEEE67CQ36795635-03B8551E-D1FA-46BF-962A-D05159C30C8AQ37324303-51AD9099-E29C-407F-8B0A-724D9A522A58Q37424716-94C3A14F-9277-4F18-B093-FA8D2B17D4D0Q37770826-1B91CF0A-5596-4652-BD82-175ABA72A4E7Q37784288-0A7629DC-471E-4D36-A309-8C8BBFD9C89AQ38264673-AEC68D7B-40F2-45A9-A198-F7375C00A605Q38445355-F94EC366-DC64-4514-9716-58198B743A84Q38683340-0C316712-7DC5-4008-A3EF-035BACEE33AEQ38754498-12BBAA71-5DB2-4825-9BC7-23C238119C96Q38763620-F7B77A7C-458D-4E04-A532-8E5523BDE442Q38898613-53DA9D0A-5ACC-43B5-9F84-4EF3E2E71A60Q39622839-297A0623-71BF-4867-83EA-9FA39968E79FQ43122068-65A8F9A5-CA50-4B2C-969B-ACED581A50ACQ44090164-09E25AFB-E344-4921-BC1B-9D5B7BE9BF0DQ52560420-E78F6735-8D32-4DD5-8D47-8BA5F9BCC1E4Q59137325-6BB2CD60-6CA0-4E4E-A6F2-7169157CD9A4
P2860
The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The interleukin-11 receptor al ...... dels, and human tumor samples.
@ast
The interleukin-11 receptor al ...... dels, and human tumor samples.
@en
type
label
The interleukin-11 receptor al ...... dels, and human tumor samples.
@ast
The interleukin-11 receptor al ...... dels, and human tumor samples.
@en
prefLabel
The interleukin-11 receptor al ...... dels, and human tumor samples.
@ast
The interleukin-11 receptor al ...... dels, and human tumor samples.
@en
P2093
P1433
P1476
The interleukin-11 receptor al ...... dels, and human tumor samples.
@en
P2093
Guiying Wang
Michael G Ozawa
Michael T Deavers
Tomo Shintani
Valerae O Lewis
Wadih Arap
P304
P356
10.1158/0008-5472.CAN-08-4845
P407
P577
2009-02-24T00:00:00Z